Trial · NCT03452228
Adverse events332
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
21 to 40 of 332
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Gastroenteritis | Infections and infestations | Placebo IV Q4W (DBTP) | 1 | 16 | 1 |
| other | Gastroenteritis | Infections and infestations | Evinacumab 15 mg/kg (DBTP) | 1 | 35 | 1 |
| other | Gastroenteritis | Infections and infestations | Evinacumab 15 mg/kg (SBTP) | 0 | 15 | 0 |
| other | Gastroenteritis | Infections and infestations | SBTP DB/SB Evinacumab IV 15mg/kg Q4W | 0 | 32 | 0 |
| other | Gastroenteritis viral | Infections and infestations | Placebo IV Q4W (DBTP) | 1 | 16 | 1 |
| other | Gastroenteritis viral | Infections and infestations | Evinacumab 15 mg/kg (DBTP) | 0 | 35 | 0 |
| other | Gastroenteritis viral | Infections and infestations | Evinacumab 15 mg/kg (SBTP) | 0 | 15 | 0 |
| other | Gastroenteritis viral | Infections and infestations | SBTP DB/SB Evinacumab IV 15mg/kg Q4W | 0 | 32 | 0 |
| other | Herpes zoster | Infections and infestations | Placebo IV Q4W (DBTP) | 0 | 16 | 0 |
| other | Herpes zoster | Infections and infestations | Evinacumab 15 mg/kg (DBTP) | 2 | 35 | 2 |
| other | Herpes zoster | Infections and infestations | Evinacumab 15 mg/kg (SBTP) | 1 | 15 | 1 |
| other | Herpes zoster | Infections and infestations | SBTP DB/SB Evinacumab IV 15mg/kg Q4W | 0 | 32 | 0 |
| other | Influenza | Infections and infestations | Placebo IV Q4W (DBTP) | 0 | 16 | 0 |
| other | Influenza | Infections and infestations | Evinacumab 15 mg/kg (DBTP) | 1 | 35 | 1 |
| other | Influenza | Infections and infestations | Evinacumab 15 mg/kg (SBTP) | 1 | 15 | 1 |
| other | Influenza | Infections and infestations | SBTP DB/SB Evinacumab IV 15mg/kg Q4W | 1 | 32 | 1 |
| other | Laryngitis | Infections and infestations | Placebo IV Q4W (DBTP) | 0 | 16 | 0 |
| other | Laryngitis | Infections and infestations | Evinacumab 15 mg/kg (DBTP) | 0 | 35 | 0 |
| other | Laryngitis | Infections and infestations | Evinacumab 15 mg/kg (SBTP) | 1 | 15 | 1 |
| other | Laryngitis | Infections and infestations | SBTP DB/SB Evinacumab IV 15mg/kg Q4W | 0 | 32 | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03452228/events?page=2